Location History:
- 10 Dalby, SE (1999)
- Dalby, SE (2000 - 2006)
- Sävar, SE (2006)
- Pixbo, SE (2020)
Company Filing History:
4 out of 7 
4 out of 1,586 
1 out of 14 Years Active: 1999-2020
Title: The Innovative Mind of Jan Kihlberg: Pioneering Advances in Autoimmune Treatments
Introduction: Jan Kihlberg, an accomplished inventor based in Dalby, Sweden, has made significant contributions to the field of autoimmune disease treatment. With a portfolio of 10 patents, Kihlberg's work focuses on developing novel compounds and methodologies that enhance understanding and management of autoimmune conditions.
Latest Patents: Among Kihlberg's latest patents is a compound comprising an autoantigenic peptide linked to a carrier with a major histocompatibility complex (MHC) binding motif. This invention outlines a compound that includes (a) a peptide with specific glycosylation and (b) a carrier featuring at least one MHC binding motif. The described pharmaceutical compositions aim to treat diseases, including inflammatory joint diseases, using peptides derived from type II collagen, such as AGFKGEA and AAAKAAA. Another recent patent centers around methods and materials for diagnosing and treating autoimmune conditions. This covers polypeptide compositions, nucleic acids, and methods for identifying and enhancing tolerance in mammals suffering from these conditions.
Career Highlights: Kihlberg's career has been marked by his development of groundbreaking inventions that bridge the gap between fundamental research and practical applications in medicine. His work at reputable companies, including Siga Pharmaceuticals, Inc., showcases his commitment to advancing healthcare through innovation.
Collaborations: Throughout his career, Jan Kihlberg has collaborated with notable researchers, including Scott J. Hultgren and Meta Kuehn. These partnerships have fostered an environment of creativity and expertise, allowing for the exploration of complex problems in the field of autoimmune diseases.
Conclusion: Jan Kihlberg exemplifies the spirit of innovation in the biotechnology sector. His impactful patents and collaborative efforts continue to pave the way for new treatments that hold promise for individuals suffering from autoimmune conditions. With a dedication to research and improvement of patient outcomes, Kihlberg stands as a beacon of creativity and scientific advancement in the global medical landscape.